Skip to main content
Top
Literature
1.
go back to reference Ghoshal UC. Indian Journal of Gastroenterology: The promises fulfilled and waiting for fulfillment! Indian J Gastroenterol. 2017;36:441–2. Ghoshal UC. Indian Journal of Gastroenterology: The promises fulfilled and waiting for fulfillment! Indian J Gastroenterol. 2017;36:441–2.
2.
go back to reference Philips CA, Paramaguru R, Joy AK, et al. Clinical outcomes, histopathological patterns, and chemical analysis of Ayurveda and herbal medicine associated with severe liver injury—A single-center experience from southern India. Indian J Gastroenterol. 2018;37:9–17. Philips CA, Paramaguru R, Joy AK, et al. Clinical outcomes, histopathological patterns, and chemical analysis of Ayurveda and herbal medicine associated with severe liver injury—A single-center experience from southern India. Indian J Gastroenterol. 2018;37:9–17.
3.
go back to reference Amarapurkar AD, Amarapurkar DN, Rathi P, et al. Risk factors for inflammatory bowel disease: A prospective multi-center study. Indian J Gastroenterol. 2018;37:189–95. Amarapurkar AD, Amarapurkar DN, Rathi P, et al. Risk factors for inflammatory bowel disease: A prospective multi-center study. Indian J Gastroenterol. 2018;37:189–95.
4.
go back to reference Philips CA, Phadke N, Ganesan K, et al. Corticosteroids, nutrition, pentoxifylline, or fecal microbiota transplantation for severe alcoholic hepatitis. Indian J Gastroenterol. 2018;37:215–25.CrossRefPubMed Philips CA, Phadke N, Ganesan K, et al. Corticosteroids, nutrition, pentoxifylline, or fecal microbiota transplantation for severe alcoholic hepatitis. Indian J Gastroenterol. 2018;37:215–25.CrossRefPubMed
5.
go back to reference Ghoshal UC, Srivastava D, Misra A. A randomized double-blind placebo-controlled trial showing rifaximin to improve constipation by reducing methane production and accelerating colon transit: a pilot study. Indian J Gastroenterol. 2018;37:416–23.CrossRefPubMed Ghoshal UC, Srivastava D, Misra A. A randomized double-blind placebo-controlled trial showing rifaximin to improve constipation by reducing methane production and accelerating colon transit: a pilot study. Indian J Gastroenterol. 2018;37:416–23.CrossRefPubMed
6.
go back to reference Saif RU, Dar HA, Sofi SM, et al. Noradrenaline versus terlipressin in the management of type 1 hepatorenal syndrome: A randomized controlled study. Indian J Gastroenterol. 2018;37:424–9. Saif RU, Dar HA, Sofi SM, et al. Noradrenaline versus terlipressin in the management of type 1 hepatorenal syndrome: A randomized controlled study. Indian J Gastroenterol. 2018;37:424–9.
7.
go back to reference Kumar A, Arora A, Sharma P, et al. Gastrointestinal and hepatic manifestations of corona virus disease-19 and their relationship to severe clinical course: A systematic review and meta-analysis. Indian J Gastroenterol. 2020;39:268–84. Kumar A, Arora A, Sharma P, et al. Gastrointestinal and hepatic manifestations of corona virus disease-19 and their relationship to severe clinical course: A systematic review and meta-analysis. Indian J Gastroenterol. 2020;39:268–84.
8.
go back to reference Shalimar, Elhence A, Vaishnav M, et al. Poor outcomes in patients with cirrhosis and corona virus disease-19. Indian J Gastroenterol. 2020;39:285–91.CrossRefPubMedPubMedCentral Shalimar, Elhence A, Vaishnav M, et al. Poor outcomes in patients with cirrhosis and corona virus disease-19. Indian J Gastroenterol. 2020;39:285–91.CrossRefPubMedPubMedCentral
9.
go back to reference Goyal O, Nohria S, Dhaliwal AS, et al. Prevalence, overlap, and risk factors for Rome IV functional gastrointestinal disorders among college students in northern India. Indian J Gastroenterol. 2021;40:144–53.CrossRefPubMed Goyal O, Nohria S, Dhaliwal AS, et al. Prevalence, overlap, and risk factors for Rome IV functional gastrointestinal disorders among college students in northern India. Indian J Gastroenterol. 2021;40:144–53.CrossRefPubMed
10.
go back to reference Zheng H, Liu YJ, Chen ZC, et al. miR-222 regulates cell growth, apoptosis, and autophagy of interstitial cells of Cajal isolated from slow transit constipation rats by targeting c-kit. Indian J Gastroenterol. 2021;40:198–208.CrossRefPubMed Zheng H, Liu YJ, Chen ZC, et al. miR-222 regulates cell growth, apoptosis, and autophagy of interstitial cells of Cajal isolated from slow transit constipation rats by targeting c-kit. Indian J Gastroenterol. 2021;40:198–208.CrossRefPubMed
11.
go back to reference Tellapuri S, Sutphin PD, Beg MS, et al. Staging systems of hepatocellular carcinoma: A review. Indian J Gastroenterol. 2018;37:481–91. Tellapuri S, Sutphin PD, Beg MS, et al. Staging systems of hepatocellular carcinoma: A review. Indian J Gastroenterol. 2018;37:481–91.
13.
go back to reference Wong SW, Chan WK. Epidemiology of non-alcoholic fatty liver disease in Asia. Indian J Gastroenterol. 2020;39:1–8.CrossRefPubMed Wong SW, Chan WK. Epidemiology of non-alcoholic fatty liver disease in Asia. Indian J Gastroenterol. 2020;39:1–8.CrossRefPubMed
14.
go back to reference Ghoshal UC, Goel A, Quigley EMM. Gut microbiota abnormalities, small intestinal bacterial overgrowth, and non-alcoholic fatty liver disease: An emerging paradigm. Indian J Gastroenterol. 2020;39:9–21. Ghoshal UC, Goel A, Quigley EMM. Gut microbiota abnormalities, small intestinal bacterial overgrowth, and non-alcoholic fatty liver disease: An emerging paradigm. Indian J Gastroenterol. 2020;39:9–21.
15.
go back to reference Tam JSY, Coller JK, Hughes PA, et al. Toll-like receptor 4 (TLR4) antagonists as potential therapeutics for intestinal inflammation. Indian J Gastroenterol. 2021;40:5–21.CrossRefPubMedPubMedCentral Tam JSY, Coller JK, Hughes PA, et al. Toll-like receptor 4 (TLR4) antagonists as potential therapeutics for intestinal inflammation. Indian J Gastroenterol. 2021;40:5–21.CrossRefPubMedPubMedCentral
16.
go back to reference DeLay K, Yadlapati R, Pandolfino JE. Chicago Classification of esophageal motility disorders: Past, present, and future. Indian J Gastroenterol. 2021;40:120–30. DeLay K, Yadlapati R, Pandolfino JE. Chicago Classification of esophageal motility disorders: Past, present, and future. Indian J Gastroenterol. 2021;40:120–30.
17.
go back to reference Ghoshal UC, Sachdeva S, Pratap N, et al. Indian consensus on chronic constipation in adults: A joint position statement of the Indian Motility and Functional Diseases Association and the Indian Society of Gastroenterology. Indian J Gastroenterol. 2018;37:526–44. Ghoshal UC, Sachdeva S, Pratap N, et al. Indian consensus on chronic constipation in adults: A joint position statement of the Indian Motility and Functional Diseases Association and the Indian Society of Gastroenterology. Indian J Gastroenterol. 2018;37:526–44.
18.
go back to reference Sood A, Ahuja V, Kedia S, et al. Diet and inflammatory bowel disease: The Asian Working Group guidelines. Indian J Gastroenterol. 2019;38:220–46. Sood A, Ahuja V, Kedia S, et al. Diet and inflammatory bowel disease: The Asian Working Group guidelines. Indian J Gastroenterol. 2019;38:220–46.
19.
go back to reference Bhatia SJ, Makharia GK, Abraham P, et al. Indian consensus on gastroesophageal reflux disease in adults: A position statement of the Indian Society of Gastroenterology. Indian J Gastroenterol. 2019;38:411–40. Bhatia SJ, Makharia GK, Abraham P, et al. Indian consensus on gastroesophageal reflux disease in adults: A position statement of the Indian Society of Gastroenterology. Indian J Gastroenterol. 2019;38:411–40.
20.
go back to reference Singh SP, Ahuja V, Ghoshal UC, et al. Management of Helicobacter pylori infection: The Bhubaneswar Consensus Report of the Indian Society of Gastroenterology. Indian J Gastroenterol. 2021;40:420–44. Singh SP, Ahuja V, Ghoshal UC, et al. Management of Helicobacter pylori infection: The Bhubaneswar Consensus Report of the Indian Society of Gastroenterology. Indian J Gastroenterol. 2021;40:420–44.
21.
go back to reference Singh SP, Wadhawan M, Acharya SK, et al. Management of portal hypertensive upper gastrointestinal bleeding: Report of the Coorg Consensus workshop of the Indian Society of Gastroenterology Task Force on Upper Gastrointestinal Bleeding. Indian J Gastroenterol. 2021;40:519–40. Singh SP, Wadhawan M, Acharya SK, et al. Management of portal hypertensive upper gastrointestinal bleeding: Report of the Coorg Consensus workshop of the Indian Society of Gastroenterology Task Force on Upper Gastrointestinal Bleeding. Indian J Gastroenterol. 2021;40:519–40.
22.
go back to reference Ghoshal UC, Sachdeva S, Ghoshal U, et al. Asian-Pacific consensus on small intestinal bacterial overgrowth in gastrointestinal disorders: An initiative of the Indian Neurogastroenterology and Motility Association. Indian J Gastroenterol. 2022;41:483–507. Ghoshal UC, Sachdeva S, Ghoshal U, et al. Asian-Pacific consensus on small intestinal bacterial overgrowth in gastrointestinal disorders: An initiative of the Indian Neurogastroenterology and Motility Association. Indian J Gastroenterol. 2022;41:483–507.
23.
go back to reference Schmulson M, Corazziari E, Ghoshal UC, et al. A four-country comparison of healthcare systems, implementation of diagnostic criteria, and treatment availability for functional gastrointestinal disorders: a report of the Rome foundation working team on cross-cultural, multinational research. Neurogastroenterol Motil. 2014;26:1368–85.CrossRefPubMed Schmulson M, Corazziari E, Ghoshal UC, et al. A four-country comparison of healthcare systems, implementation of diagnostic criteria, and treatment availability for functional gastrointestinal disorders: a report of the Rome foundation working team on cross-cultural, multinational research. Neurogastroenterol Motil. 2014;26:1368–85.CrossRefPubMed
Metadata
Title
Indian Journal of Gastroenterology 2018–2022: Looking back from the Editor’s desk!
Author
Uday C. Ghoshal
Publication date
11-03-2023
Publisher
Springer India
Published in
Indian Journal of Gastroenterology / Issue 1/2023
Print ISSN: 0254-8860
Electronic ISSN: 0975-0711
DOI
https://doi.org/10.1007/s12664-023-01340-0

Other articles of this Issue 1/2023

Indian Journal of Gastroenterology 1/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine